Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNTE
2701
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.1M | ﹤0.01% |
90,050
+1,409
| +2% | +$35.8K |
|
2702
Altimmune
ALT
$546M
| $2.09M | ﹤0.01% |
212,550
+76,056
| +56% | +$1.04M |
|
|
TCS
2703
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.09M | ﹤0.01% |
10,695
-3,069
| -22% | -$638K |
|
|
VIA
2704
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $2.09M | ﹤0.01% |
36,811
-12,384
| -25% | -$661K |
|
2705
Globant
GLOB
$1.58B
| $2.08M | ﹤0.01% |
9,492
+3,333
| +54% | +$733K |
|
2706
Prelude Therapeutics
PRLD
$384M
| $2.08M | ﹤0.01% |
72,623
-2,045
| -3% | -$72.8K |
|
2707
RPC Inc
RES
$1.23B
| $2.07M | ﹤0.01% |
418,402
+17,410
| +4% | +$93.8K |
|
|
PRTK
2708
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.06M | ﹤0.01% |
302,670
+28,130
| +10% | +$227K |
|
|
GTYH
2709
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $2.04M | ﹤0.01% |
287,444
-14,621
| -5% | -$88.9K |
|
2710
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $2.02M | ﹤0.01% |
71,531
+1,327
| +2% | +$37K |
|
|
TRIL
2711
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.01M | ﹤0.01% |
+207,353
| New | +$1.95M |
|
2712
Korro Bio
KRRO
$149M
| $2.01M | ﹤0.01% |
4,036
+61
| +2% | +$29.8K |
|
2713
Vera Bradley
VRA
$99M
| $2.01M | ﹤0.01% |
162,129
+18,071
| +13% | +$206K |
|
2714
Lifecore Biomedical
LFCR
$163M
| $2M | ﹤0.01% |
177,895
+5,057
| +3% | +$58.3K |
|
|
CARM
2715
DELISTED
Carisma Therapeutics
CARM
| $1.99M | ﹤0.01% |
21,519
+18,701
| +664% | +$1.19M |
|
2716
Peoples Financial Services
PFIS
$702M
| $1.98M | ﹤0.01% |
46,424
+1,509
| +3% | +$64.9K |
|
2717
Preformed Line Products
PLPC
$1.76B
| $1.98M | ﹤0.01% |
26,615
+5,396
| +25% | +$389K |
|
2718
Cognyte Software
CGNT
$652M
| $1.97M | ﹤0.01% |
80,557
-130,171
| -62% | -$3.22M |
|
|
ADN
2719
DELISTED
Advent Technologies
ADN
| $1.97M | ﹤0.01% |
6,816
+1,358
| +25% | +$452K |
|
2720
McEwen Inc
MUX
$1.04B
| $1.97M | ﹤0.01% |
142,395
+18,717
| +15% | +$248K |
|
|
SCPL
2721
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $1.96M | ﹤0.01% |
115,770
+9,512
| +9% | +$164K |
|
2722
Byrna Technologies
BYRN
$101M
| $1.96M | ﹤0.01% |
+86,284
| New | +$2.13M |
|
2723
SIGA Technologies
SIGA
$232M
| $1.96M | ﹤0.01% |
311,659
-9,245
| -3% | -$63.5K |
|
2724
Sutro Biopharma
STRO
$408M
| $1.93M | ﹤0.01% |
10,400
+2,260
| +28% | +$442K |
|
2725
Park Aerospace
PKE
$743M
| $1.93M | ﹤0.01% |
129,389
+3,481
| +3% | +$50.2K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.